EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method



Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method



Journal of Clinical Microbiology 42(3): 1109-1114



The performance of the fully automated BACTEC MGIT 960 (M960) system for the testing of Mycobacterium tuberculosis susceptibility to streptomycin (SM), isoniazid (INH), rifampin (RMP), ethambutol (EMB), and pyrazinamide (PZA) was evaluated with 100 clinical isolates and compared to that of the radiometric BACTEC 460TB (B460) system. The agar proportion method and the B460 system were used as reference methods to resolve the discordant results for SM, INH, RMP, and EMB (a combination known as SIRE) and PZA, respectively. The overall agreements were 96.3% for SIRE and 92% for PZA. For SIRE, a total of 26 discrepancies were found and were resolved in favor of the M960 system in 8 cases and in favor of the B460 system in 18 cases. The M960 system produced 8 very major errors (VME) and 10 major errors (ME), while the B460 system showed 4 VME and 4 ME. No statistically significant differences were found. Both systems exhibited excellent performance, but a higher number of VME was observed with the M960 system at the critical concentrations of EMB and SM. For PZA, a total of eight discrepancies were observed and were resolved in favor of the M960 system in one case and in favor of the B460 system in seven cases; no statistically significant differences were found. The M960 system showed four VME and three ME. The mean times to report overall PZA results and resistant results were 8.2 and 9.8 days, respectively, for the M960 system and 7.4 and 8.1 days, respectively, for the B460 system. Statistically significant differences were found. The mean times to report SIRE results were 8.3 days for the M960 system and 8.2 days for the B460 system. No statistically significant differences were found. Twelve strains tested for SIRE susceptibility and seven strains tested for PZA susceptibility had been reprocessed because of contamination. In conclusion, the M960 system can represent a valid alternative to the B460 for M. tuberculosis susceptibility testing; however, the frequent contamination of the tests needs to be improved.

(PDF emailed within 0-6 h: $19.90)

Accession: 049000949

Download citation: RISBibTeXText

PMID: 15004061

DOI: 10.1128/JCM.42.3.1109-1114.2004



Related references

Multicenter evaluation of the fully automated Bactec MGIT 960 system for susceptibility testing of Mycobacterium tuberculosis to pyrazinamide: comparison with the radiometric Bactec 460TB system. Journal of Microbiological Methods 55(1): 331-333, 2003

Evaluation of automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to four major antituberculous drugs: comparison with the radiometric BACTEC 460TB method and the agar plate method of proportion. Journal of Clinical Microbiology 40(2): 607-610, 2002

Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to front line antituberculosis drugs and comparison with the radiometric BACTEC 460 TB method. Mikrobiyoloji Bulteni 43(3): 403-409, 2010

Susceptibility testing of Mycobacterium tuberculosis to rifampin and isoniazid BACTEC MGIT 960 vs BACTEC 460 TB System. Abstracts of the General Meeting of the American Society for Microbiology 100: 129-130, 2000

Multicenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis. Journal of Clinical Microbiology 45(6): 1766-1770, 2007

Evaluation of automated BACTEC MGIT 960 system for susceptibility testing to pyrazinamide of Mycobacterium tuberculosis. Abstracts of the General Meeting of the American Society for Microbiology 103: C-222, 2003

Susceptibility testing of Mycobacterium tuberculosis to pyrazinamide by the non-radiometric BACTEC MGIT 960 system. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 155, 2000

Evaluation of the BacT/ALERT PZA kit in comparison with the BACTEC 460TB PZA for testing Mycobacterium tuberculosis susceptibility to pyrazinamide. Journal of Antimicrobial ChemoTherapy 60(3): 655-657, 2007

Evaluation of the fully automated Bactec MGIT 960 system for the susceptibility testing of Mycobacterium tuberculosis to first-line drugs: a multicenter study. Journal of Microbiological Methods 56(2): 291-294, 2004

Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system. Journal of Clinical Microbiology 40(5): 1670-1674, 2002

Direct Susceptibility Testing of Mycobacterium tuberculosis for Pyrazinamide by Use of the Bactec MGIT 960 System. Journal of Clinical Microbiology 54(5): 1276-1281, 2016

A method to perform BACTEC 460TB system susceptibility testing from BBL MGIT mycobacteria growth indicator tubes containing M tuberculosis. Abstracts of the General Meeting of the American Society for Microbiology 95(0): 28, 1995

Comparison of turnaround times (TAT) for Mycobacterium tuberculosis (Mtb) complex susceptibility testing results generated with radiometric BACTEC 460 (B) and non-radiometric MGIT 960 (M). 2005

Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide. Journal of Clinical Microbiology 48(1): 300-301, 2010

Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis. Journal of Clinical Microbiology 39(12): 4440-4444, 2001